CERVICAL CARCINOMA
Clinical trials for CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell attack: new hope for advanced cervical cancer?
Disease control TerminatedThis study tested a personalized treatment called LN-145 for people with cervical cancer that had come back or spread. The treatment uses a patient's own immune cells (tumor-infiltrating lymphocytes) that are grown in a lab and then given back to fight the cancer. The trial aimed…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Engineered immune cells take on HPV-driven cervical cancer
Disease control TerminatedThis early-phase trial tested a new cell therapy called TC-E202 for people with advanced cervical cancer that had stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells infected with HPV16. The study…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC